HRMY
Harmony Biosciences Holdings, Inc.Company with tickers: HRMY
CIK
1802665
Shares Outstanding
57,867,389
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-04-07 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Tax | 3,173 |
| 2026-04-07 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Convert | 7,500 |
| 2026-04-07 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Convert | 7,500 |
| 2026-04-02 | Anastasiou Peter | Director | Award | 212,241 |
| 2026-04-02 | Ignelzi Troy A. | Director | Award | 17,710 |
| 2026-04-02 | Ignelzi Troy A. | Director | Other | 0 |
| 2026-01-26 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Sell | 3,746 |
| 2026-01-25 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 4,725 |
| 2026-01-25 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 4,725 |
| 2026-01-25 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Tax | 2,553 |
| 2026-01-25 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Convert | 13,000 |
| 2026-01-25 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Convert | 13,000 |
| 2026-01-25 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Tax | 5,654 |
| 2026-01-25 | Serafin Andrew | CHIEF STRATEGY OFFICER | Tax | 1,126 |
| 2026-01-25 | Serafin Andrew | CHIEF STRATEGY OFFICER | Convert | 2,600 |
| 2026-01-25 | Serafin Andrew | CHIEF STRATEGY OFFICER | Convert | 2,600 |
| 2026-01-25 | Budur Kumar | CHIEF MEDICAL OFFICER | Tax | 1,372 |
| 2026-01-25 | Budur Kumar | CHIEF MEDICAL OFFICER | Convert | 2,662 |
| 2026-01-25 | Budur Kumar | CHIEF MEDICAL OFFICER | Convert | 2,662 |
| 2026-01-24 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 3,813 |
| 2026-01-24 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 3,813 |
| 2026-01-24 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Tax | 2,239 |
| 2026-01-24 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Convert | 10,500 |
| 2026-01-24 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Tax | 4,785 |
| 2026-01-24 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Convert | 10,500 |
| 2026-01-24 | Serafin Andrew | CHIEF STRATEGY OFFICER | Convert | 2,500 |
| 2026-01-24 | Serafin Andrew | CHIEF STRATEGY OFFICER | Convert | 2,500 |
| 2026-01-24 | Serafin Andrew | CHIEF STRATEGY OFFICER | Tax | 1,116 |
| 2026-01-24 | Budur Kumar | CHIEF MEDICAL OFFICER | Convert | 2,188 |
| 2026-01-24 | Budur Kumar | CHIEF MEDICAL OFFICER | Tax | 1,153 |
| 2026-01-24 | Budur Kumar | CHIEF MEDICAL OFFICER | Convert | 2,188 |
| 2026-01-22 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Award | 12,200 |
| 2026-01-22 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Award | 42,600 |
| 2026-01-22 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Award | 52,900 |
| 2026-01-22 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Award | 184,600 |
| 2026-01-22 | Serafin Andrew | CHIEF STRATEGY OFFICER | Award | 42,600 |
| 2026-01-22 | Serafin Andrew | CHIEF STRATEGY OFFICER | Award | 12,200 |
| 2026-01-22 | Budur Kumar | CHIEF MEDICAL OFFICER | Award | 42,600 |
| 2026-01-22 | Budur Kumar | CHIEF MEDICAL OFFICER | Award | 12,200 |
| 2026-01-22 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Award | 16,200 |
| 2026-01-22 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Award | 56,900 |
| 2026-01-15 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Sell | 20,961 |
| 2025-12-12 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Convert | 20,000 |
| 2025-12-12 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Sell | 20,000 |
| 2025-12-12 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Convert | 20,000 |
| 2025-12-05 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 20,000 |
| 2025-12-05 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 20,000 |
| 2025-12-05 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Sell | 20,000 |
| 2025-11-21 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Sell | 3,427 |
| 2025-09-30 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 45,000 |
| 2025-09-30 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Tax | 24,039 |
| 2025-09-30 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 45,000 |
| 2025-08-28 | Valor IV Pharma Holdings, LLC | 10% Owner | Other | 6,618,033 |
| 2025-08-15 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Sell | 21,573 |
| 2025-05-25 | Graf R. Mark | Director | Award | 14,522 |
| 2025-05-15 | Philip Ron M | Director | Award | 14,522 |
| 2025-05-15 | Anastasiou Peter | Director | Award | 14,522 |
| 2025-05-15 | Sabater Juan A. | Director | Award | 14,522 |
| 2025-05-15 | Gracias Antonio J. | Director | Award | 14,522 |
| 2025-05-15 | Szyper Linda M | Director | Award | 14,522 |
| 2025-05-15 | Sender Gary | Director | Award | 14,522 |
| 2025-05-01 | Budur Kumar | CHIEF MEDICAL OFFICER | Convert | 18,750 |
| 2025-05-01 | Budur Kumar | CHIEF MEDICAL OFFICER | Tax | 8,869 |
| 2025-05-01 | Budur Kumar | CHIEF MEDICAL OFFICER | Convert | 18,750 |
| 2025-04-07 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Award | 30,000 |
| 2025-04-07 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Award | 100,000 |
| 2025-04-07 | Zaeske Adam H. | CHIEF COMMERCIAL OFFICER | Other | 0 |
| 2025-04-02 | Philip Ron M | Director | Award | 14,077 |
| 2025-04-02 | Philip Ron M | Director | Other | 0 |
| 2025-04-01 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Sell | 6,247 |
| 2025-03-29 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 15,000 |
| 2025-03-29 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 15,000 |
| 2025-03-29 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Tax | 8,014 |
| 2025-03-03 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 4,369 |
| 2025-03-03 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Convert | 4,869 |
| 2025-03-03 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Convert | 4,869 |
| 2025-01-27 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 1,629 |
| 2025-01-27 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Sell | 1,775 |
| 2025-01-25 | Budur Kumar | CHIEF MEDICAL OFFICER | Award | 37,400 |
| 2025-01-25 | Budur Kumar | CHIEF MEDICAL OFFICER | Award | 10,650 |
| 2025-01-25 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Award | 47,200 |
| 2025-01-25 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Award | 13,450 |
| 2025-01-25 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Award | 180,000 |
| 2025-01-25 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Award | 52,000 |
| 2025-01-25 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Award | 18,900 |
| 2025-01-25 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Award | 66,250 |
| 2025-01-25 | Serafin Andrew | CHIEF STRATEGY OFFICER | Award | 10,400 |
| 2025-01-25 | Serafin Andrew | CHIEF STRATEGY OFFICER | Award | 36,500 |
| 2025-01-24 | Budur Kumar | CHIEF MEDICAL OFFICER | Tax | 1,151 |
| 2025-01-24 | Budur Kumar | CHIEF MEDICAL OFFICER | Convert | 2,187 |
| 2025-01-24 | Budur Kumar | CHIEF MEDICAL OFFICER | Convert | 2,187 |
| 2025-01-24 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Sell | 8,000 |
| 2025-01-24 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Tax | 1,058 |
| 2025-01-24 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Convert | 13,125 |
| 2025-01-24 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Convert | 13,125 |
| 2025-01-24 | Dierks Jeffrey | CHIEF COMMERCIAL OFFICER | Convert | 2,687 |
| 2025-01-24 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Convert | 10,500 |
| 2025-01-24 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Tax | 4,567 |
| 2025-01-24 | Dayno Jeffrey M. | Director, PRESIDENT, CEO | Convert | 10,500 |
| 2025-01-24 | Kapadia Sandip | CHIEF FINANCIAL OFFICER | Convert | 3,812 |